We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

48 hedge funds and large institutions have $25.1M invested in Infinity Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

7% more capital invested

Capital invested by funds: $23.4M → $25.1M (+$1.74M)

0% more funds holding

Funds holding: 48 → 48 (0)

Holders
48
Holders Change
–
Holders Change %
0%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
13
Reduced
8
Closed
5
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$234K
2
Millennium Management
Millennium Management
New York
+$24.4K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$23.8K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$16.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$15K

Top Sellers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
-$238K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$92.7K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$77.2K
4
SC
Savant Capital
Illinois
-$21K
5
Victory Capital Management
Victory Capital Management
Texas
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$23K +$24.4K +25,651 New
CB
27
Community Bank
New York
$22K – – –
AFG
28
American Financial Group
Ohio
$18K – – –
Ameriprise
29
Ameriprise
Minnesota
$15K +$2.19K +2,300 +16%
Osaic Holdings
30
Osaic Holdings
Arizona
$13K – – –
Two Sigma Investments
31
Two Sigma Investments
New York
$12K -$4.38K -4,600 -25%
AA
32
AlphaMark Advisors
Kentucky
$11K +$3K +3,150 +35%
VF
33
Virtu Financial
New York
$11K +$11.7K +12,283 New
MML Investors Services
34
MML Investors Services
Massachusetts
$10K +$10.2K +10,741 New
FP
35
Financial Perspectives
Minnesota
$9.05K – – –
Morgan Stanley
36
Morgan Stanley
New York
$9K +$1.56K +1,640 +21%
Wells Fargo
37
Wells Fargo
California
$8K -$827 -868 -9%
Group One Trading
38
Group One Trading
Illinois
$8K – – –
UBS Group
39
UBS Group
Switzerland
$2K -$1.62K -1,698 -47%
Bank of America
40
Bank of America
North Carolina
$2K – – –
Canada Pension Plan Investment Board
41
Canada Pension Plan Investment Board
Ontario, Canada
$2K – – –
GRP
42
Global Retirement Partners
California
$1K – – –
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1K +$155 +163 +16%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$1 – – –
SC
45
Savant Capital
Illinois
– -$21K -25,000 Closed
Victory Capital Management
46
Victory Capital Management
Texas
– -$16K -18,704 Closed
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$15K -17,685 Closed
Citadel Advisors
48
Citadel Advisors
Florida
– -$14K -16,165 Closed
AF
49
Advisornet Financial
Minnesota
– -$2K -2,104 Closed
SPIA
50
Steward Partners Investment Advisory
New York
– -$1.43K -1,500 -94%
1
2
3

INFI Hedge Fund Activity: Q2 2020 in Review

48 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q2 2020, worth a combined $25.1M — up 7.4% from $23.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new INFI positions and 5 closed out — a net gain of 1 holder — while 13 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $234K. The largest seller was Bleichroeder LP, cutting an estimated $238K.

  • 48 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $25.1M of Infinity Pharmaceuticals, Inc. stock for Q2 2020, up 7.4% quarter-over-quarter.
  • 6 funds opened new Infinity Pharmaceuticals, Inc. positions in Q2 2020 and 5 closed out, a net change of +1 holder.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q2 2020 was Renaissance Technologies, an estimated $234K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q2 2020 was Bleichroeder LP, an estimated $238K sold.

Based on aggregated 13F filings for Q2 2020.